Patient benefits of maintenance immunotherapy-Reference-Cited by-同舟云学术

Patient benefits of maintenance immunotherapy

Published:2006-01 Issue: Volume:30 Page:S22-S26
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Ghielmini Michele

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference28 articles.

1. CVP chemotherapy plus rituximab compared with CVP as firstline treatment for advanced follicular lymphoma;Marcus;Blood,2005

2. Rituximab added to IFN+CHVP improves the outcome of follicular lymphoma patients with a high tumor burden: first analysis of the GELA-GOELAMS FL-2000 randomized trial in 359 patients;Salles;Blood,2004

3. The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

4. Rituximab plus mitoxantrone, chlorambucil, prednisolon (R-MCP) is superior to MCP alone in advanced indolent and follicular lymphoma — results of a phase III study (OSHO39);Herold;Ann Oncol,2005

5. The role of rituximab maintenance treatment in relapsed follicular NHL: an interim analysis of the EORTC randomized intergroup trial;Hagenbeek;Ann Oncol,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma;Hematology;2014-07-16

2. Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials;JNCI: Journal of the National Cancer Institute;2011-12-07

3. Monoclonal Antibodies in Paediatric Acute Lymphoblastic Leukemia;New Agents for the Treatment of Acute Lymphoblastic Leukemia;2011

4. Rituximab as maintenance therapy for patients with follicular lymphoma;Cochrane Database of Systematic Reviews;2009-04-15

5. Antibody-based therapeutic strategies for malignant lymphomas;memo - Magazine of European Medical Oncology;2009-03